Two Sigma Investments’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
VI
MF
FLAM
AAM
KLCMU
RSCM
Two Sigma Investments's XENT Position: Q4 2021 in Review
Two Sigma Investments sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 84,300 shares — an estimated $2.29M sold.
Two Sigma Investments first reported a position in XENT in Q2 2015 and held it in 17 quarters. The position peaked at $5.11M in Q4 2020. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.
- Two Sigma Investments reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
- Two Sigma Investments sold 84,300 Intersect ENT, Inc shares in Q4 2021, an estimated $2.29M.
- Two Sigma Investments first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 17 quarters.
- Two Sigma Investments's Intersect ENT, Inc position peaked at $5.11M in Q4 2020.
- 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.
Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.